Emerging Therapeutic Options for the Management of COPD.

about

Clinical potential of aclidinium bromide in chronic obstructive pulmonary disease

P2860

Q38223379-CB530A8B-FFEC-44FF-9F44-2547729CA1E3

P2860

Emerging Therapeutic Options for the Management of COPD.

Item

http://www.wikidata.org/entity/Q39936577

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Emerging Therapeutic Options for the Management of COPD.

@en

Emerging Therapeutic Options for the Management of COPD.

@nl

type

Item

label

Emerging Therapeutic Options for the Management of COPD.

@en

Emerging Therapeutic Options for the Management of COPD.

@nl

prefLabel

Emerging Therapeutic Options for the Management of COPD.

@en

Emerging Therapeutic Options for the Management of COPD.

@nl

P1476

Emerging Therapeutic Options for the Management of COPD.

@en

P2093

Debra J Reid

http://www.w3.org/2001/XMLSchema#string

Nga T Pham

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of indacaterol 150 microg once-daily in COPD: a double-blind, randomised, 12-week study

Chronic obstructive pulmonary disease

The effect of tiotropium on exacerbations and airflow in patients with COPD.

Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials.

Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial.

ABCD of the phosphodiesterase family: interaction and differential activity in COPD

Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease

Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile.

Profile of aclidinium bromide in the treatment of chronic obstructive pulmonary disease

Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial.

P304

7-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4137/CCRPM.S8140

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23641160

http://www.w3.org/2001/XMLSchema#string

P932

3629926

http://www.w3.org/2001/XMLSchema#string

Emerging Therapeutic Options for the Management of COPD.

about

P2860

P2860

Emerging Therapeutic Options for the Management of COPD.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932